​
Login / Signup
Eunjee Lee
(EunJee Lee)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 6
Top Topics
Epithelial Mesenchymal Transition
Poor Prognosis
Cell Death
Signaling Pathway
Top Venues
Cancer research communications
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Koichi Ito
,
Ibuki Harada
,
Criseyda Martinez
,
Katsutoshi Sato
,
Eunjee Lee
,
Elisa Port
,
Jessica H Byerly
,
Anupma Nayak
,
Ekta Tripathi
,
Jun Zhu
,
Hanna Y Irie
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Cancer research communications
4 (3) (2024)
Koichi Ito
,
Ibuki Harada
,
Criseyda Martinez
,
Katsutoshi Sato
,
Eunjee Lee
,
Elisa Port
,
Jessica H Byerly
,
Anupma Nayak
,
Ekta Tripathi
,
Jun Zhu
,
Hanna Y Irie
MARCH2, a novel oncogene-regulated SNAIL E3 ligase, suppresses triple negative breast cancer metastases.
Cancer research communications
(2024)
Koichi Ito
,
Ibuki Harada
,
Criseyda Martinez
,
Katsutoshi Sato
,
Eunjee Lee
,
Elisa Port
,
Jessica H Byerly
,
Anupma Nayak
,
Ekta Tripathi
,
Jun Zhu
,
Hanna Y Irie
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Cancer research communications
4 (3) (2024)
Koichi Ito
,
Ibuki Harada
,
Criseyda Martinez
,
Katsutoshi Sato
,
Eunjee Lee
,
Elisa Port
,
Jessica H Byerly
,
Anupma Nayak
,
Ekta Tripathi
,
Jun Zhu
,
Hanna Y Irie
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Cancer research communications
4 (3) (2024)
Koichi Ito
,
Ibuki Harada
,
Criseyda Martinez
,
Katsutoshi Sato
,
Eunjee Lee
,
Elisa Port
,
Jessica H Byerly
,
Anupma Nayak
,
Ekta Tripathi
,
Jun Zhu
,
Hanna Y Irie
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Cancer research communications
4 (3) (2024)
Maximillian S Westphal
,
Eunjee Lee
,
Eric E Schadt
,
Giselle S Sholler
,
Jun Zhu
Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma.
Cancers
14 (1) (2021)